Quick Facts
  • wavy circle icon with check mark inside
  • magnifying glass with heart icon
    Medical Oncology
  • gender symbols interlocked icon
  • chat box with different language translations icon
  • pin location icon
    Primary Location:
    Lung Institute at Baylor College of Medicine

Sabichi is involved in experimental therapeutics of lung, head and neck cancers. She helped investigate a clinical trial involving bevacizumab in the treatment of head and neck cancers. Bevacizumab, also known by brand name Avastin, was recently added to the National Comprehensive Cancer Network’s first-line mesothelioma treatment recommendations.

Contact Dr. Anita Lyn Sabichi

Sabichi, who has been in practice for more than 20 years, graduated from the University of Colorado School of Medicine. She completed her residency at New York Presbyterian Hospital and her fellowship at the National Institutes of Health Clinical Center.

In 2021, Dr. Sabichi published a research study on anti-PD-1 monotherapy, outlining the clinical benefits as first-line therapy for malignant pleural mesothelioma patients.